BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27824767)

  • 21. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
    Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J
    Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
    Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
    J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.
    Moore G; Fetterman B; Cox JT; Poitras N; Lorey T; Kinney W; Castle PE
    J Low Genit Tract Dis; 2010 Apr; 14(2):97-102. PubMed ID: 20354416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
    JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
    Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Robertson M; Castle PE;
    Int J Cancer; 2014 Aug; 135(3):624-34. PubMed ID: 24226935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK; Chan RC; Nichols WS; Bose S
    Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of visual inspection with acetic acid in detecting high-grade cervical intraepithelial neoplasia in pre- and post-menopausal Thai women with minor cervical cytological abnormalities.
    Poomtavorn Y; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(6):2327-31. PubMed ID: 25824759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of High-Grade Cervical Lesions in Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology: Comparison between HIV-Infected and HIV-Negative Women.
    Srisomboon S; Tantipalakorn C; Muangmool T; Srisomboon J
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):547-551. PubMed ID: 33639672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Implementing the Dual Papanicolaou Test Interpretation of ASC-H and LSIL Following Bethesda 2014.
    Goyal A; Patel AP; Dilcher TL; Alperstein SA
    Am J Clin Pathol; 2020 Sep; 154(4):553-558. PubMed ID: 32556080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical squamous cells of undetermined significance cervical cytology in the Chinese population: Age-stratified reporting rates, high-risk HPV testing, and immediate histologic correlation results.
    Tao X; Zhang H; Wang L; Pan Q; Ji S; Zhou X; Zhao C
    Cancer Cytopathol; 2021 Jan; 129(1):24-32. PubMed ID: 32697438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
    Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S43-9. PubMed ID: 23519304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
    Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
    J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.